KR20210144811A - 벤조아제핀 화합물-함유 제약 조성물 - Google Patents

벤조아제핀 화합물-함유 제약 조성물 Download PDF

Info

Publication number
KR20210144811A
KR20210144811A KR1020217034478A KR20217034478A KR20210144811A KR 20210144811 A KR20210144811 A KR 20210144811A KR 1020217034478 A KR1020217034478 A KR 1020217034478A KR 20217034478 A KR20217034478 A KR 20217034478A KR 20210144811 A KR20210144811 A KR 20210144811A
Authority
KR
South Korea
Prior art keywords
metal salt
formula
pharmaceutical composition
minutes
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020217034478A
Other languages
English (en)
Korean (ko)
Inventor
도미히코 치하라
싱고 우노
Original Assignee
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오츠카 세이야쿠 가부시키가이샤 filed Critical 오츠카 세이야쿠 가부시키가이샤
Publication of KR20210144811A publication Critical patent/KR20210144811A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020217034478A 2019-03-28 2020-03-27 벤조아제핀 화합물-함유 제약 조성물 Pending KR20210144811A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019064357 2019-03-28
JPJP-P-2019-064357 2019-03-28
PCT/JP2020/013935 WO2020196816A1 (en) 2019-03-28 2020-03-27 Benzoazepine compound-containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
KR20210144811A true KR20210144811A (ko) 2021-11-30

Family

ID=70289832

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217034478A Pending KR20210144811A (ko) 2019-03-28 2020-03-27 벤조아제핀 화합물-함유 제약 조성물

Country Status (7)

Country Link
US (1) US20220152064A1 (https=)
EP (1) EP3946362A1 (https=)
JP (3) JP7130879B2 (https=)
KR (1) KR20210144811A (https=)
CN (1) CN113631169A (https=)
EA (1) EA202192635A1 (https=)
WO (1) WO2020196816A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121081404B (zh) * 2025-11-12 2026-02-06 北京藏卫信康医药研发有限公司 含有托伐普坦磷酸钠的药物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007074915A1 (en) 2005-12-27 2007-07-05 Otsuka Pharmaceutical Co., Ltd. Water-soluble benzoazepine compound and its pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5590780B2 (ja) 2007-06-26 2014-09-17 大塚製薬株式会社 医薬
TW201605488A (zh) * 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
KR20210144810A (ko) * 2019-03-28 2021-11-30 오츠카 세이야쿠 가부시키가이샤 벤조아제핀 화합물-함유 동결건조 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007074915A1 (en) 2005-12-27 2007-07-05 Otsuka Pharmaceutical Co., Ltd. Water-soluble benzoazepine compound and its pharmaceutical composition

Also Published As

Publication number Publication date
US20220152064A1 (en) 2022-05-19
JP2022519343A (ja) 2022-03-23
JP2025081484A (ja) 2025-05-27
JP7130879B2 (ja) 2022-09-05
JP2022163190A (ja) 2022-10-25
EA202192635A1 (ru) 2021-12-10
EP3946362A1 (en) 2022-02-09
WO2020196816A1 (en) 2020-10-01
CN113631169A (zh) 2021-11-09

Similar Documents

Publication Publication Date Title
US10946030B2 (en) Formulations of deoxycholic acid and salts thereof
KR102034606B1 (ko) 데옥시콜린산 및 그의 염들의 제형물들
JP7043156B2 (ja) ベンゾアゼピン化合物含有凍結乾燥組成物
EP3305298B1 (en) Formulations of deoxycholic acid and salts thereof
JP2025081484A (ja) ベンゾアゼピン化合物含有医薬組成物
EP2620153A1 (en) 5 alpha-androstane (alkyl)-3 beta,5,6 beta-triol injection and preparation method therefor
EP1166773B1 (en) Solution of N- O(p-pivaloyloxbenzenesulfonylamino)benzoyl glycine monosodium salt tetra-hydrate and drug product thereof
NL8102362A (nl) Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.
HK40063746A (en) Benzoazepine compound-containing pharmaceutical composition
EA045403B1 (ru) Лиофилизированная композиция, содержащая соединение бензоазепина
HK40063745A (en) Benzoazepine compound-containing freeze-dried composition
HK40063745B (zh) 含有苯并氮杂卓化合物的冻干组合物
JPS6330422A (ja) 抗悪性腫瘍効果増強剤
EA034320B1 (ru) Композиции дезоксихолата натрия

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000